Biggest News Aggregation in the World
📰 Eva News

Page 77 - Eva News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Eva. Real-time updates on events, politics, business and more.

Teva, Viatris win new chance to challenge J&J schizophrenia drug patent

(Reuters) -Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to a patent covering a blockbuster Johnson & Johnson schizophrenia drug, giving them a new chance to clear a path to launch cheaper generic versions of the medicine. The U.S. Court of Appeals for the Federal Circuit said that the last remaining J&J patent covering its Invega Sustenna may be invalid, sending the case back for a New Jersey federal court to reconsider. A J&#x2...
United States New Jersey Alexia Garamfalvi Blake Brittain Claire Cecchi Invega Sustenna
Source: yahoo.com

Deva: Pavail Gulati opens up on his preparation for the film, 'I felt compelled to immerse myself fully in the physical demands of the role'

Directed by Rosshan Andrrews and produced by Zee Studios and Roy Kapur Films, Deva is an action-packed film which also stars Pooja Hegde. The film will hit cinemas on Dussehra this October. | Tellychakkar.com
Pavail Gulati Rashmika Madan Ashwiny Tiwari Iyer Shahid Kapoor Rosshan Andrrews Taapsee Pannu

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Enviva Inc. (NYSE:EVA) Receives Consensus Rating of "Reduce" from Brokerages

Shares of Enviva Inc. (NYSE:EVA – Get Free Report) have received a consensus rating of “Reduce” from the six brokerages that are currently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and one has issued a buy recommendation on the company. The […]
United Kingdom Raymond James Plustick Management Capital Partners Jpmorgan Chase Co Enviva Inc

Enviva Inc. (NYSE:EVA) Given Average Recommendation of "Reduce" by Brokerages

Shares of Enviva Inc. (NYSE:EVA – Get Free Report) have earned an average recommendation of “Reduce” from the six ratings firms that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and one has assigned a buy recommendation to the company. […]
United Kingdom Raymond James Jpmorgan Chase Co Enviva Inc Barclays Plc European Union

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science